614
Views
58
CrossRef citations to date
0
Altmetric
Clinical focus: Clinical Immunology & Infectious diseases - Original Research

Characterizing the gut microbiota in patients with chronic kidney disease

ORCID Icon, ORCID Icon, , ORCID Icon &
Pages 495-505 | Received 14 Feb 2020, Accepted 16 Mar 2020, Published online: 02 Apr 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Fan Wang, Chang Liu, LingZhi Ren, YanYang Li, HongMei Yang, Yang Yu & WeiPing Xu. (2023) Sanziguben polysaccharides improve diabetic nephropathy in mice by regulating gut microbiota to inhibit the TLR4/NF-κB/NLRP3 signalling pathway. Pharmaceutical Biology 61:1, pages 427-436.
Read now
Shulan Guo, Huan Wu, Ji Ji, Zhaoxing Sun, Bo Xiang, Weiwei Wu, Jun Ji, Jie Teng, Xiaoqiang Ding & Xiaofang Yu. (2023) Association between gut microbial diversity and technique failure in peritoneal dialysis patients. Renal Failure 45:1.
Read now
Anjing Wang, Jin Zhao, Yunlong Qin, Yumeng Zhang, Yan Xing, Yuwei Wang, Zixian Yu, Jipeng Yan, Mei Han, Jinguo Yuan, Yueqing Hui, Shuxian Guo, Xiaoxuan Ning & Shiren Sun. (2023) Alterations of the gut microbiota in the lupus nephritis: a systematic review. Renal Failure 45:2.
Read now
Jin Zhao, Xiaoxuan Ning, Baojian Liu, Ruijuan Dong, Ming Bai & Shiren Sun. (2021) Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review. Renal Failure 43:1, pages 102-112.
Read now

Articles from other publishers (53)

Jian-Xiu Yu, Xin Chen, Su-Gang Zang, Xi Chen, Yan-Yan Wu, Li-Pei Wu & Shi-Hai Xuan. (2024) Gut microbiota microbial metabolites in diabetic nephropathy patients: far to go. Frontiers in Cellular and Infection Microbiology 14.
Crossref
Xingzheng Liu, Jinying Mo, Xuerui Yang, Ling Peng, Youjia Zeng, Yihou Zheng & Gaofeng Song. (2024) Causal relationship between gut microbiota and chronic renal failure: a two-sample Mendelian randomization study. Frontiers in Microbiology 15.
Crossref
Emmanouil Mavrogeorgis, Sophie Valkenburg, Justyna Siwy, Agnieszka Latosinska, Griet Glorieux, Harald Mischak & Joachim Jankowski. (2024) Integration of Urinary Peptidome and Fecal Microbiome to Explore Patient Clustering in Chronic Kidney Disease. Proteomes 12:2, pages 11.
Crossref
An Samaey, Jorge Francisco Vázquez-Castellanos, Clara Caenepeel, Pieter Evenepoel, Séverine Vermeire, Jeroen Raes & Noël Knops. (2023) Effects of fecal microbiota transplantation for recurrent Clostridium difficile infection in children on kidney replacement therapy: a pilot study. Pediatric Nephrology 39:4, pages 1201-1212.
Crossref
Ricardo Araujo, Ana Merino-Ribas, Luciano Pereira, Joana Campos, Nádia Silva, Inês Soares Alencastre, Manuel Pestana & Benedita Sampaio-Maia. (2024) The urogenital microbiome in chronic kidney disease patients on peritoneal dialysis. Nefrología (English Edition) 44:2, pages 194-203.
Crossref
Ricardo Araujo, Ana Merino-Ribas, Luciano Pereira, Joana Campos, Nádia Silva, Inês Soares Alencastre, Manuel Pestana & Benedita Sampaio-Maia. (2024) The urogenital microbiome in chronic kidney disease patients on peritoneal dialysis. Nefrología 44:2, pages 194-203.
Crossref
Chenyang Ji, Jiahui Miao, Nan Zhao, Yaoyao Dai, Jiawen Yang, Jianli Qu, Jianqiang Zhu & Meirong Zhao. (2024) N-nitrosamines induced gender-dimorphic effects on infant rats at environmental levels. Science of The Total Environment 912, pages 169196.
Crossref
I-Wen Wu, Lun-Ching Chang, Yi-Lun Wu, Huang-Yu Yang, Yuh-Ching Twu, Po-Yu Tsai, Skyler Paulus, Rhian Resnick, Wen-Hung Chung, Chih-Wei Yang, Wen-Ping Hsieh & Shih-Chi Su. (2024) Gut flora metagenomic analysis coupled with metabolic and deep immune profiling in chronic kidney disease. Nephrology Dialysis Transplantation.
Crossref
Karen S Coutinho-Wolino, Manuela F S Melo, Jessica C Mota, Denise Mafra, Jonas T Guimarães & Milena B Stockler-Pinto. (2024) Blueberry, cranberry, raspberry, and strawberry as modulators of the gut microbiota: target for treatment of gut dysbiosis in chronic kidney disease? From current evidence to future possibilities. Nutrition Reviews 82:2, pages 248-261.
Crossref
Shirin Pourafshar, Binu Sharma, Jenifer Allen, Madeleine Hoang, Hannah Lee, Holly Dressman, Crystal C. Tyson, Indika Mallawaarachchi, Pankaj Kumar, Jennie Z. Ma, Pao-Hwa Lin & Julia J. Scialla. (2024) Longitudinal Pilot Evaluation of the Gut Microbiota Comparing Patients With and Without Chronic Kidney Disease. Journal of Renal Nutrition.
Crossref
Feihong Ren, Qiubai Jin, Qi Jin, Yiyun Qian, Xuelei Ren, Tongtong Liu & Yongli Zhan. (2023) Genetic evidence supporting the causal role of gut microbiota in chronic kidney disease and chronic systemic inflammation in CKD: a bilateral two-sample Mendelian randomization study. Frontiers in Immunology 14.
Crossref
Denise Mafra, Julie A. Kemp, Ludmila F.M.F. Cardozo, Natália A. Borges, Fabiana B. Nerbass, Lívia Alvarenga & Kamyar Kalantar-Zadeh. (2023) COVID-19 and Nutrition: Focus on Chronic Kidney Disease. Journal of Renal Nutrition 33:6, pages S118-S127.
Crossref
Hao-Jie Zhong, Xinqiang Xie, Wen-Jia Chen, Yu-Pei Zhuang, Xuan Hu, Ying-Li Cai, Hong-Lie Zeng, Chuanxing Xiao, Ying Li, Yu Ding, Liang Xue, Moutong Chen, Jumei Zhang, Qingping Wu & Xing-Xiang He. (2023) Washed microbiota transplantation improves renal function in patients with renal dysfunction: a retrospective cohort study. Journal of Translational Medicine 21:1.
Crossref
Georgia Saxami, Evangelia Kerezoudi, Christos Eliopoulos, Dimitrios Arapoglou & Adamantini Kyriacou. (2023) The Gut–Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics. Life 13:10, pages 2023.
Crossref
Ping Liu, Jianli Yang, Yu Chen, Yifan Zhu, Yuyan Tang, Xudong Xu & Haidong He. (2023) Alterations of gut microbiota and metabolome in early chronic kidney disease patients complicated with hyperuricemia. Heliyon 9:9, pages e20328.
Crossref
Na T.D. Tran, Apisit Chaidee, Achirawit Surapinit, Manachai Yingklang, Sitiruk Roytrakul, Sawanya Charoenlappanit, Porntip Pinlaor, Nuttanan Hongsrichan, Hai Nguyen Thi, Sirirat Anutrakulchai, Ubon Cha'on & Somchai Pinlaor. (2023) Strongyloides stercoralis infection reduces Fusicatenibacter and Anaerostipes in the gut and increases bacterial amino-acid metabolism in early-stage chronic kidney disease. Heliyon 9:9, pages e19859.
Crossref
Acharya Balkrishna, Sugandh Sinha, Ashwani Kumar, Vedpriya Arya, Ajay Kumar Gautam, Martin Valis, Kamil Kuca, Dinesh Kumar & Ryszard Amarowicz. (2023) Sepsis-mediated renal dysfunction: Pathophysiology, biomarkers and role of phytoconstituents in its management. Biomedicine & Pharmacotherapy 165, pages 115183.
Crossref
Kyung-Ryung Kim, Seon-Myung Kim & Jung-Hyun Kim. (2023) A pilot study of alterations of the gut microbiome in canine chronic kidney disease. Frontiers in Veterinary Science 10.
Crossref
Xiu-Nan Zhao, Shu-Xin Liu, Zhen-Zhen Wang, Shuang Zhang & Lian-Lian You. (2023) Roxadustat alleviates the inflammatory status in patients receiving maintenance hemodialysis with erythropoiesis-stimulating agent resistance by increasing the short-chain fatty acids producing gut bacteria. European Journal of Medical Research 28:1.
Crossref
Yonglin Wu, Miaomiao Pan, Zheng Zou, Xingyu Rong, Hao Yang, Zhenming Xiao, Huijing Wang, Tao Liu, Wu Huang, Meifang Shi & Chao Zhao. (2023) Urinary microbiota shift is associated with a decline in renal function. Life Medicine 2:3.
Crossref
Mikhail O. Pyatchenkov, Svetlana P. Salikova, Evgeniy V. Sherbakov & Andrey A. Vlasov. (2023) The state of the intestinal microbial-tissue complex in patients with chronic kidney disease. Bulletin of the Russian Military Medical Academy 25:1, pages 155-164.
Crossref
Luminita Voroneanu, Alexandru Burlacu, Crischentian Brinza, Andreea Covic, Gheorghe G. Balan, Ionut Nistor, Cristina Popa, Simona Hogas & Adrian Covic. (2023) Gut Microbiota in Chronic Kidney Disease: From Composition to Modulation towards Better Outcomes—A Systematic Review. Journal of Clinical Medicine 12:5, pages 1948.
Crossref
Xuan Wang, Fei Li, Nana Zhang, Emilio Ungerfeld, Long Guo, Xiumin Zhang, Min Wang & Zhiyuan Ma. (2023) Effects of supplementing a yeast culture in a pelleted total mixed ration on fiber degradation, fermentation parameters, and the bacterial community in the rumen of sheep. Animal Feed Science and Technology 296, pages 115565.
Crossref
Lin Zheng, Mingjing Luo, Haokui Zhou & Jianping Chen. (2023) Natural products from plants and microorganisms: Novel therapeutics for chronic kidney disease via gut microbiota regulation. Frontiers in Pharmacology 13.
Crossref
Haichao Wang, Aisima Ainiwaer, Yaxiang Song, Ling Qin, Ai Peng, Hui Bao & Huanlong Qin. (2023) Perturbed gut microbiome and fecal and serum metabolomes are associated with chronic kidney disease severity. Microbiome 11:1.
Crossref
Renata Rodrigues Teixeira, Laila Santos de Andrade, Natalia Barros Ferreira Pereira, Horacio Montenegro, Christian Hoffmann & Lilian Cuppari. (2022) Gut microbiota profile of patients on peritoneal dialysis: comparison with household contacts. European Journal of Clinical Nutrition 77:1, pages 90-97.
Crossref
Jun Zhou, Cuishun Yang, Wenjuan Lei, Zhen Yang, Jianmei Chen, Hua Lin, Qingtian Li & Wanqiong Yuan. (2022) Exploration of the correlation between intestinal flora and Escherichia coli peritoneal dialysis-related peritonitis. BMC Nephrology 23:1.
Crossref
Livia Alvarenga, Ludmila F.M.F. Cardozo, Viviane de O. Leal, Julie A. Kemp, Juliana F. Saldanha, Marcelo Ribeiro-Alves, Tassiana Meireles, Lia S. Nakao & Denise Mafra. (2022) Can Resveratrol Supplementation Reduce Uremic Toxin Plasma Levels From the Gut Microbiota in Nondialyzed Patients With Chronic Kidney Disease?. Journal of Renal Nutrition 32:6, pages 685-691.
Crossref
Minnie Jacob, Refat M. Nimer, Mohamad S. Alabdaljabar, Essa M. Sabi, Mysoon M. Al-Ansari, Maged Housien, Khalid M. Sumaily, Lina A. Dahabiyeh & Anas M. Abdel Rahman. (2022) Metabolomics Profiling of Nephrotic Syndrome towards Biomarker Discovery. International Journal of Molecular Sciences 23:20, pages 12614.
Crossref
Jun Zhou, Cuishun Yang, Wenjuan Lei, Zhen Yang, Jianmei Chen & Hua Lin. (2022) Exploration of the correlation between intestinal flora and peritoneal dialysis-related peritonitis. Clinical and Experimental Nephrology 26:10, pages 1030-1038.
Crossref
Julie Ann Kemp, Livia Alvarenga, Ludmila F. M. F. Cardozo, Lu Dai, Peter Stenvinkel, Paul G. Shiels, Tilman M. Hackeng, Leon J. Schurgers & Denise Mafra. (2022) Dysbiosis in Patients with Chronic Kidney Disease: Let Us Talk About Vitamin K. Current Nutrition Reports 11:4, pages 765-779.
Crossref
Mostafa Asgharian, Pourya Gholizadeh, Hossein Samadi Kafil, Morteza Ghojazadeh, Azam Samadi, Jafar Soleymani, Abolghasem Jouyban & Hamid Tayebi Khosroshahi. (2022) Correlation of inflammatory biomarkers with the diversity of Bacteroidaceae, Bifidobacteriaceae, Prevotellaceae and Lactobacillaceae families in the intestinal microbiota of patients with end stage renal disease. Advances in Medical Sciences 67:2, pages 304-310.
Crossref
Xi Cheng, Tingting Zhou, Yanqiu He, Yumei Xie, Yong Xu & Wei Huang. (2022) The role and mechanism of butyrate in the prevention and treatment of diabetic kidney disease. Frontiers in Microbiology 13.
Crossref
Yu Tian, Chaoqun Gu, Feng Yan, Yifeng Gu, Yangkun Feng, Jie Chen, Jiayi Sheng, Lei Hu, Peng Jiang, Wei Guo & Ninghan Feng. (2022) Alteration of Skin Microbiome in CKD Patients Is Associated With Pruritus and Renal Function. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Ji Bian, Ann Liebert, Brian Bicknell, Xin-Ming Chen, Chunling Huang & Carol A. Pollock. (2022) Faecal Microbiota Transplantation and Chronic Kidney Disease. Nutrients 14:12, pages 2528.
Crossref
Jialin Hu, Shichao Wei, Yifeng Gu, Yang Wang, Yangkun Feng, Jiayi Sheng, Lei Hu, Chaoqun Gu, Peng Jiang, Yu Tian, Wei Guo, Longxian Lv, Fengping Liu, Yeqing Zou, Feng Yan & Ninghan Feng. (2022) Gut Mycobiome in Patients With Chronic Kidney Disease Was Altered and Associated With Immunological Profiles. Frontiers in Immunology 13.
Crossref
Cuiping Liu, Shibo Zhang, Hongwei Shi, Haicong Zhou, Junyi Zhuang, Yiyang Cao, Natalie Ward & Jiao Wang. (2022) Atp11b Deletion Affects the Gut Microbiota and Accelerates Brain Aging in Mice. Brain Sciences 12:6, pages 709.
Crossref
Esti Widiasih, Hertanto Wahyu Subagio & Lestariningsih Lestariningsih. (2022) The Role of Gut Dysbiosis in Malnutrition Mechanism in CKD-5 HD Patients. Open Access Macedonian Journal of Medical Sciences 10:E, pages 1016-1023.
Crossref
Haolin Chen, Ning Zhang, Yonglei Wu, Chenjie Yang, Qionghong Xie, Chunhui Deng & Nianrong Sun. (2022) Investigation of Urinary Exosome Metabolic Patterns in Membranous Nephropathy by Titania‐Assisted Intact Exosome Mass Spectrometry. Small Science 2:5.
Crossref
Maja Mizdrak, Marko Kumrić, Tina Tičinović Kurir & Joško Božić. (2022) Emerging Biomarkers for Early Detection of Chronic Kidney Disease. Journal of Personalized Medicine 12:4, pages 548.
Crossref
Ye-juan Jia, Tian-yu Li, Peng Han, Yu Chen, Li-jia Pan & Chun-sheng Jia. (2022) Effects of different courses of moxibustion treatment on intestinal flora and inflammation of a rat model of knee osteoarthritis. Journal of Integrative Medicine 20:2, pages 173-181.
Crossref
Chunlan Ji, Fuhua Lu, Yuchi Wu, Zhaoyu Lu, Yenan Mo, Lijuan Han, Qizhan Lin, Xusheng Liu & Chuan Zou. (2022) Rhubarb Enema Increasing Short-Chain Fatty Acids that Improves the Intestinal Barrier Disruption in CKD May Be Related to the Regulation of Gut Dysbiosis. BioMed Research International 2022, pages 1-15.
Crossref
Ana Merino-Ribas, Carolina F.F.A. Costa, Maria Azevedo, Inês Alencastre, Manuel Pestana, Ricardo Araujo & Benedita Sampaio-Maia. 2022. Human-Gut Microbiome. Human-Gut Microbiome 233 263 .
Helen Tremlett, Feng Zhu, Douglas Arnold, Amit Bar‐Or, Charles N. Bernstein, Christine Bonner, Jessica D. Forbes, Morag Graham, Janace Hart, Natalie C. Knox, Ruth Ann Marrie, Ali I. Mirza, Julia O’Mahony, Gary Van Domselaar, E. Ann Yeh, Yinshan Zhao, Brenda Banwell & Emmanuelle Waubant. (2021) The gut microbiota in pediatric multiple sclerosis and demyelinating syndromes. Annals of Clinical and Translational Neurology 8:12, pages 2252-2269.
Crossref
Qing Zhang, Yanmei Zhang, Lu Zeng, Guowei Chen, La Zhang, Meifang Liu, Hongqin Sheng, Xiaoxuan Hu, Jingxu Su, Duo Zhang, Fuhua Lu, Xusheng Liu & Lei Zhang. (2021) The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease. Frontiers in Pharmacology 12.
Crossref
Renato C. Monteiro & Laureline Berthelot. (2021) Role of gut–kidney axis in renal diseases and IgA nephropathy. Current Opinion in Gastroenterology 37:6, pages 565-571.
Crossref
Julie Ann Kemp, Bruna Regis de Paiva, Henrique Fragoso dos Santos, Hugo Emiliano de Jesus, Hannah Craven, Umer Z. Ijaz, Natalia Alvarenga Borges, Paul G. Shiels & Denise Mafra. (2021) The Impact of Enriched Resistant Starch Type‐2 Cookies on the Gut Microbiome in Hemodialysis Patients: A Randomized Controlled Trial. Molecular Nutrition & Food Research 65:19.
Crossref
Carla Morales-Ferré, Ignasi Azagra-Boronat, Malén Massot-Cladera, Sebastian Tims, Karen Knipping, Johan Garssen, Jan Knol, Àngels Franch, Margarida Castell, María J. Rodríguez-Lagunas & Francisco J. Pérez-Cano. (2021) Effects of a Postbiotic and Prebiotic Mixture on Suckling Rats’ Microbiota and Immunity. Nutrients 13:9, pages 2975.
Crossref
Xi Du, Jia Liu, Yu Xue, Xiangyun Kong, Chunxiao Lv, Ziqiang Li, Yuhong Huang & Baohe Wang. (2021) Alteration of gut microbial profile in patients with diabetic nephropathy. Endocrine 73:1, pages 71-84.
Crossref
Natalia Stepanova. (2021) Role of Impaired Oxalate Homeostasis in Cardiovascular Disease in Patients With End-Stage Renal Disease: An Opinion Article. Frontiers in Pharmacology 12.
Crossref
Juraj Bosák, Matej Lexa, Kristýna Fiedorová, Darshak C. Gadara, Lenka Micenková, Zdenek Spacil, Jiří Litzman, Tomáš Freiberger & David Šmajs. (2021) Patients With Common Variable Immunodeficiency (CVID) Show Higher Gut Bacterial Diversity and Levels of Low-Abundance Genes Than the Healthy Housemates. Frontiers in Immunology 12.
Crossref
Dan Luo, Wenbo Zhao, Zhiming Lin, Jianhao Wu, Hongchun Lin, Yongjie Li, Jun Song, Jun Zhang & Hui Peng. (2021) The Effects of Hemodialysis and Peritoneal Dialysis on the Gut Microbiota of End-Stage Renal Disease Patients, and the Relationship Between Gut Microbiota and Patient Prognoses. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Wu Yonglin, Pan Miaomiao, Zou Zheng, Rong Xingyu, Yang Hao, Xiao Zhenming, Wang Huijing, Liu Tao, Huang Wu, Shi Meifang & Zhao Chao. (2022) Urinary Microbiota Shift is Associated with a Decline in Renal Function in the Aging Kidney. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.